EMBO Molecular Medicine (Jul 2017)

MSTO1 is a cytoplasmic pro‐mitochondrial fusion protein

  • Aniko Gal,
  • Peter Balicza,
  • David Weaver,
  • Shamim Naghdi,
  • Suresh K Joseph,
  • Péter Várnai,
  • Tibor Gyuris,
  • Attila Horváth,
  • Laszlo Nagy,
  • Erin L Seifert,
  • Maria Judit Molnar,
  • György Hajnóczky

DOI
https://doi.org/10.15252/emmm.201607058
Journal volume & issue
Vol. 9, no. 7
pp. 967 – 984

Abstract

Read online

Abstract The protein MSTO1 has been localized to mitochondria and linked to mitochondrial morphology, but its specific role has remained unclear. Lactate stress test and myopathological results suggest mitochondrial dysfunction. In patient fibroblasts, MSTO1 mRNA and protein abundance are decreased, mitochondria display fragmentation, aggregation, and decreased network continuity and fusion activity. Short‐term silencing of MSTO1 in HeLa cells reproduced the impairment of mitochondrial morphology and dynamics observed in the fibroblasts without damaging bioenergetics. At variance with a previous report, we find MSTO1 to be localized in the cytoplasmic area with limited colocalization with mitochondria. MSTO1 interacts with the fusion machinery as a soluble factor at the cytoplasm‐mitochondrial outer membrane interface. After plasma membrane permeabilization, MSTO1 is released from the cells. MSTO1 likely has a physiologically relevant role in mitochondrial morphogenesis by supporting mitochondrial fusion.§

Keywords